WHO endorses twice-yearly injection for HIV prevention
The World Health Organisation (WHO) has endorsed the use of the long-acting injectable antiretroviral drug lenacapavir for HIV prevention. This twice-yearly injection is recommended as an additional option for pre-exposure prophylaxis (PrEP), offering a long-acting alternative to daily oral medications. It’s given once every six months, and according to experts, it offers sustained protection against…